Terms: = Pancreatic cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Treatment
296 results:
1. [A Case of Advanced Gastric cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy].
Sekino N; Natsume T; Tanaka H; Kainuma O; Sato Y; Note H; Yoshioka T; Kamata T; Odera H; Uchiyama M; Maruyama T; Takahashi H; Hirano S
Gan To Kagaku Ryoho; 2024 Apr; 51(4):417-420. PubMed ID: 38644309
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies.
Dziadek S; Kraxner A; Cheng WY; Ou Yang TH; Flores M; Theiss N; Tsao TS; Andersson E; Harring SV; Bröske AE; Ceppi M; Teichgräber V; Charo J
Front Immunol; 2024; 15():1352615. PubMed ID: 38558814
[TBL] [Abstract] [Full Text] [Related]
3. Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer.
Li Z; Mo F; Guo K; Ren S; Wang Y; Chen Y; Schwartz PB; Richmond N; Liu F; Ronnekleiv-Kelly SM; Hu Q
Med; 2024 Apr; 5(4):348-367.e7. PubMed ID: 38521069
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma.
Ren Y; Wu R; Li C; Liu L; Li L; Weng S; Xu H; Xing Z; Zhang Y; Wang L; Liu Z; Han X
BMC Biol; 2024 Mar; 22(1):69. PubMed ID: 38519942
[TBL] [Abstract] [Full Text] [Related]
5. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
6. A Comparison of Spatial and Phenotypic Immune Profiles of pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
7. Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy.
Li YS; Ye LY; Luo YX; Zheng WJ; Si JX; Yang X; Zhang YN; Wang SB; Zou H; Jin KT; Ge T; Cai Y; Mou XZ
Acta Biomater; 2024 Apr; 179():243-255. PubMed ID: 38458511
[TBL] [Abstract] [Full Text] [Related]
8. 4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.
Li H; Liu J; Wang S; Xu Y; Tang Q; Ying G
Aging (Albany NY); 2024 Mar; 16(5):4327-4347. PubMed ID: 38451188
[TBL] [Abstract] [Full Text] [Related]
9. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way.
Balar PC; Apostolopoulos V; Chavda VP
Eur J Pharmacol; 2024 Apr; 969():176451. PubMed ID: 38408598
[TBL] [Abstract] [Full Text] [Related]
10. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
Wang J; Gai J; Zhang T; Niu N; Qi H; Thomas DL; Li K; Xia T; Rodriguez C; Parkinson R; Durham J; McPhaul T; Narang AK; Anders RA; Osipov A; Wang H; He J; Laheru DA; Herman JM; Lee V; Jaffee EM; Thompson ED; Zhu Q; Zheng L
Sci Adv; 2024 Feb; 10(6):eadk1827. PubMed ID: 38324679
[TBL] [Abstract] [Full Text] [Related]
12. Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy.
Yu B; Jing P; Gao F; Zhang P; Zheng G; Zhang X
Front Immunol; 2023; 14():1315468. PubMed ID: 38313432
[TBL] [Abstract] [Full Text] [Related]
13. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of ATM promotes pd-l1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
15. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
[TBL] [Abstract] [Full Text] [Related]
16. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
[TBL] [Abstract] [Full Text] [Related]
17. Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of pd-l1.
Ren W; Xu Z; Chang Y; Ju F; Wu H; Liang Z; Zhao M; Wang N; Lin Y; Xu C; Chen S; Rao Y; Lin C; Yang J; Liu P; Zhang J; Huang C; Xia N
Nat Commun; 2024 Jan; 15(1):9. PubMed ID: 38167274
[TBL] [Abstract] [Full Text] [Related]
18. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and pdl1 expression.
Chen S; Zhou B; Huang W; Li Q; Yu Y; Kuang X; Huang H; Wang W; Xie P
Cell Death Dis; 2023 Dec; 14(12):830. PubMed ID: 38097536
[TBL] [Abstract] [Full Text] [Related]
19. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review.
Regalla DKR; Deep O; Paluri RK
Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310
[TBL] [Abstract] [Full Text] [Related]
20. Blocking MARCO
Ding L; Qian J; Yu X; Wu Q; Mao J; Liu X; Wang Y; Guo D; Su R; Xie H; Yin S; Zhou L; Zheng S
Cancer Lett; 2024 Feb; 582():216568. PubMed ID: 38065400
[TBL] [Abstract] [Full Text] [Related]
[Next]
